首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cell death & disease

缩写:CELL DEATH DIS

ISSN:2041-4889

e-ISSN:2041-4889

IF/分区:9.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引11867
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Tao Wang,Hai-Yan Yang,Xing Wang et al. Tao Wang et al.
Osimertinib is the standard first-line therapy for EGFR-mutant lung adenocarcinoma; however, the inevitable development of acquired resistance leads to disease progression and treatment failure. While established resistance mechanisms prima...
Sally K Y To,Yibin Yang,Zeyu Shi et al. Sally K Y To et al.
Intratumoral heterogeneity in metastatic cancers complicates effective treatment, as distinct tumor subclones display varying drug sensitivities and metastatic capabilities, interacting through mechanisms that remain poorly understood. In t...
Wancui Zhu,Yilin Li,Zizhen Li et al. Wancui Zhu et al.
Acquired resistance to sorafenib remains a major obstacle in the treatment of advanced hepatocellular carcinoma (HCC). While inducing ferroptosis represents a promising strategy to overcome this resistance, the specific molecular drivers un...
Yao Liang,Yuli Zheng,Zhimou Cai et al. Yao Liang et al.
Melanoma is a highly aggressive skin cancer with biologically distinct subtypes. Acral melanoma (AM), a rare but particularly aggressive form, often presents with lymph node (LN) metastasis at diagnosis. Despite its clinical severity, the m...
Na Liu,Guohu Han,Qianhui Gu et al. Na Liu et al.
Certain characteristics, such as high heterogeneity, a complex tumor microenvironment, metastatic potential, and drug resistance, render Lung cancer (LC) a formidable challenge for clinical management. With rapid advancements in high-throug...
Hui Huang,Kaixiang Ni,Chenhua Li et al. Hui Huang et al.
Glioblastoma (GBM) frequently activates hypoxia signaling even under normoxic conditions, yet the mechanism sustaining hypoxia-inducible factor-1α (HIF-1α) stability remains unclear. Here, we identify the E3 ubiquitin ligase TRIM25 as a k...
Xiao-Bo Huang,Xin-Peng Yang,Hua-Long Zheng et al. Xiao-Bo Huang et al.
Aberrant alternative splicing (AS) in cancer generates oncogenic proteomic diversity that drives tumor progression. Given the suboptimal efficacy of immune checkpoint inhibitors (ICIs) in gastric cancer (GC), the therapeutic potential of mo...
Albert Giralt,Tiago Mendes,Enrica Montalban et al. Albert Giralt et al.
Synaptic activity results in long-lasting alterations of neuronal properties, which require gene expression regulation. PYK2 is a calcium-activated non-receptor protein tyrosine kinase highly expressed in hippocampal neurons and involved in...
Guangzhao Pan,Qianqian Xu,Kui Zhang et al. Guangzhao Pan et al.
Platinum-based drugs exhibit potent anti-tumor efficacy but are limited by low bioavailability, severe toxicity, and resistance. Current therapeutic strategies lack effective solutions due to the unclear molecular mechanisms. Autophagy, wit...
Eliana Urbini,Annalisa Adamo,Yushu Hu et al. Eliana Urbini et al.
Cellular FLICE (FADD-like IL-1β-converting enzyme)-inhibitory protein (c-FLIP) was discovered more than three decades ago and has since emerged as a multifunctional regulator of cell fate. Initially identified through its homology with vir...